Search

everythinglearnresearchcommunity

for

Search:↓

Combining genetic and physical trait analysis improves diagnosis accuracy for monogenic diabetes.

Targeting ATM could help manage heart cell enlargement due to pressure overload.

Certain genetic variations in IL18 may increase the risk of alopecia areata in Koreans.

Targeting specific biomarkers and immune signals is more effective and safer for treating inflammatory skin diseases.

CD28 is a promising target for treating alopecia areata with belatacept.

CD28 is a promising target for treating alopecia areata with belatacept.

Targeting the p300/AR axis may help treat polycystic ovary syndrome.

Researchers found potential new targets for treating melanoma and nonmelanoma skin cancers, and identified a possible cause and treatment for male pattern baldness and eczema.

Androgenetic alopecia treatments focus on reducing hair loss by targeting hormones, with new therapies showing promise but needing more research.

Alopecia areata needs new treatments targeting autoimmune processes due to its emotional impact and variable treatment responses.

Certain genetic changes in the LSS gene cause a rare skin and hair condition.

Surgical debridement and targeted therapies can effectively heal chronic wounds in KID syndrome.

Early genetic testing and new therapies like secukinumab are crucial for managing Netherton syndrome effectively.

Bullous pemphigoid is influenced by genetic factors, immune cell dysfunction, aging, and triggers, with treatment often improving symptoms.

Recent findings suggest that genetic factors, immune system issues, and skin cell defects might contribute to the development of hidradenitis suppurativa.

AGA is a genetic, hormonal hair loss treated with finasteride, minoxidil, and supplements, but new compounds are being developed.

PCOS involves immune and genetic factors, with key roles for T cells and specific genes.

PCOS involves genetic and immune factors, especially T cells, affecting its development.

Three specific genetic variants cause severe skin issues in children with EBS, highlighting the need for early genetic screening.

Six new risk spots for early hair loss were found, which also link to Parkinson's disease and lower fertility. Two genes, FOXA2 and HDAC4, could be new treatment targets. Hair loss might also be connected to heart disease, metabolic syndrome, and prostate cancer.

A new genetic tool improves the study of hair growth and potential hair disorder treatments.

Colorectal cancer development involves both genetic changes and epigenetic alterations like DNA methylation and microRNA changes.

Behçet's Disease may be caused by genetic and environmental factors leading to abnormal immune responses, and stress management and new treatments could improve patient outcomes.

Fibrodysplasia ossificans progressiva is a rare genetic disorder that causes extra bone growth and symptoms of premature aging.

CD201+ fascia progenitors are essential for wound healing and could be targeted for treating skin conditions.

New treatments for hair loss include low-dose oral minoxidil, light therapy, and innovative therapies targeting hair growth mechanisms.

PCOS-related acne can be managed by targeting hormones and insulin resistance.

A new test helps find drugs to treat head and neck cancer by targeting c-Rel.

New nanocarriers were developed for safer, targeted drug delivery and diagnostics, showing promise for future medical use.

PCOS is a genetic disorder affecting women's reproductive health, with treatments focused on symptoms like insulin resistance and fertility.